UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1)

Journal of translational medicine, 2021-01, Vol.19 (1), p.21-21, Article 21

2021

Link zum Volltext

Verfügbarkeit prüfen

Harnessing Antitumor CD4 + T Cells for Cancer Immunotherapy

Cancers, 2022-01, Vol.14 (1), p.260

2022

Link zum Volltext

Verfügbarkeit prüfen

Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy

Frontiers in immunology, 2024-03, Vol.15, p.1202017-1202017

2024

Link zum Volltext

Verfügbarkeit prüfen

Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells

Cancers, 2022-06, Vol.14 (13), p.3168

2022

Link zum Volltext

Verfügbarkeit prüfen

Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001478

2020

Link zum Volltext

Verfügbarkeit prüfen

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine

Vaccines, 2015-06, Vol.3 (3), p.490-502

2015

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine

PloS one, 2014-10, Vol.9 (10), p.e108848

2014

Link zum Volltext

Verfügbarkeit prüfen

Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer

Oncoimmunology, 2019-02, Vol.8 (2), p.e1527498-e1527498

2019

Link zum Volltext

Verfügbarkeit prüfen

SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts

Oncoimmunology, 2018-04, Vol.7 (4), p.e1412030-e1412030

2018

Link zum Volltext

Verfügbarkeit prüfen

CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy

Cancer gene therapy, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

Oncoimmunology, 2012-12, Vol.1 (9), p.1617-1619

2012

Link zum Volltext

Verfügbarkeit prüfen

An unmet need: Harmonization of IL-7 and IL-15 combination for the ex vivo generation of minimally differentiated T cells

Cellular immunology, 2021-05, Vol.363, p.104314-104314, Article 104314

2021

Link zum Volltext

Verfügbarkeit prüfen

Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma

Journal of investigative dermatology, 2022-02, Vol.142 (2), p.435-444

2022

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma

Oncoimmunology, 2018-05, Vol.7 (5), p.e1423170-e1423170

2018

Link zum Volltext

Verfügbarkeit prüfen

CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin

International journal of cancer, 2019-12, Vol.145 (11), p.3112-3125

2019

Link zum Volltext

Verfügbarkeit prüfen

Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells

Cancer gene therapy, 2022-07, Vol.29 (7), p.961-972

2022

Link zum Volltext

Verfügbarkeit prüfen

L29-3 CAR CD123 : exemple d’un CAR-T académique

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2023-11, Vol.30, p.S30

2023

Link zum Volltext

Verfügbarkeit prüfen

Pour comprendre : l’activation lymphocytaire T

Bulletin du cancer, 2016-11, Vol.103, p.S127-S131

2016

Link zum Volltext

Verfügbarkeit prüfen

Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas

PloS one, 2010-01, Vol.5 (1), p.e8437

2010

Link zum Volltext

Verfügbarkeit prüfen

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14), p.4100-4112

2016

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response

Clinical cancer research, 2012-05, Vol.18 (10), p.2943-2953

2012

Link zum Volltext

Verfügbarkeit prüfen

CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes

International journal of cancer, 2015-07, Vol.137 (1), p.116-126

2015

Link zum Volltext

Verfügbarkeit prüfen

Immunité spécifique anti-télomérase dans le mélanome

Annales de dermatologie et de vénéréologie, 2020-11, Vol.147 (11), p.A22-A23

2020

Link zum Volltext

Verfügbarkeit prüfen

Echinococcus multilocularis vesicular fluid induces the expression of immune checkpoint proteins in vitro

Parasite immunology, 2020-06, Vol.42 (6), p.e12711-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(79)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1)

Harnessing Antitumor CD4 + T Cells for Cancer Immunotherapy

Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy

Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells

Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine

Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine

Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer

SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts

CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

An unmet need: Harmonization of IL-7 and IL-15 combination for the ex vivo generation of minimally differentiated T cells

Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma

PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma

CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin

Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells

L29-3 CAR CD123 : exemple d’un CAR-T académique

CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm

Pour comprendre : l’activation lymphocytaire T

Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity

Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response

CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes

Immunité spécifique anti-télomérase dans le mélanome

Echinococcus multilocularis vesicular fluid induces the expression of immune checkpoint proteins in vitro

Suchergebnisse filtern